Literature DB >> 29959814

Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) vs standard RARP: it's time for critical appraisal.

Thomas Stonier1, Nick Simson1, John Davis2, Ben Challacombe3.   

Abstract

Keywords:  Retzius-sparing; prostate cancer; radical prostatectomy

Mesh：

Year:  2018        PMID： 29959814     DOI： 10.1111/bju.14468

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  5 in total

1.  Challenging cases in high-risk prostate cancer patients treated with Retzius-sparing robot-assisted radical prostatectomy.

Authors:  Stefano Tappero; Paolo Dell'Oglio; Mattia Longoni; Carlo Buratto; Erika Palagonia; Pietro Scilipoti; Enrico Vecchio; Marco Martiriggiano; Silvia Secco; Alberto Olivero; Michele Barbieri; Giancarlo Napoli; Elena Strada; Giovanni Petralia; Dario Di Trapani; Aldo Massimo Bocciardi; Antonio Galfano
Journal:  World J Urol       Date:  2022-06-30       Impact factor: 3.661

Review 2.  Surgical techniques to improve continence recovery after robot-assisted radical prostatectomy.

Authors:  Ahmet Urkmez; Weranja Ranasinghe; John W Davis
Journal:  Transl Androl Urol       Date:  2020-12

3.  Transvesical Retzius-Sparing Versus Standard Robot-Assisted Radical Prostatectomy: A Retrospective Propensity Score-Adjusted Analysis.

Authors:  Wen Deng; Hao Jiang; Xiaoqiang Liu; Luyao Chen; Weipeng Liu; Cheng Zhang; Xiaochen Zhou; Bin Fu; Gongxian Wang
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

4.  Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.

Authors:  Joel E Rosenberg; Jae Hung Jung; Zach Edgerton; Hunju Lee; Solam Lee; Caitlin J Bakker; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2020-08-18

5.  Retzius-sparing robot-assisted laparoscopic radical prostatectomy: functional and early oncologic results in aggressive and locally advanced prostate cancer.

Authors:  Joanne Nyaboe Nyarangi-Dix; Magdalena Görtz; Georgi Gradinarov; Luisa Hofer; Viktoria Schütz; Claudia Gasch; Jan Philipp Radtke; Markus Hohenfellner
Journal:  BMC Urol       Date:  2019-11-12       Impact factor: 2.264
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.